Posted on
Free online program for patients and caregivers
Date: Wednesday, December 11, 2019
Time: 3:00 PM – 4:15 PM ET
(Support for this patient education program provided by Grifols and coproduced with NeuroCareLive)
Intravenous immunoglobulin (IVIG) is a treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Over the course of several hours, naturally occurring antibodies from healthy volunteers are given through a vein. IVIG is the only CIDP treatment that has received FDA, Canadian and European approval, and newer preparations of higher concentrations – called subcutaneous, or subQ – are being tested currently.
Join us for a free, live video education program that will help families facing CIDP:
- Compare different treatment options with doctors
- Understand side effects of each option, and learn how they can be managed
- Make an IVIG treatment strategy in partnership with care teams